The Liver Leaders Council

The Liver Leaders Council (LLC) is a corporate partnership program launched by the AASLD Foundation in 2023 which will engage industry partners annually through a portfolio of benefits, services, and strategic stakeholder conversations offered by both AASLD and the AASLD Foundation.

In addition to a portfolio of discounts, event participation opportunities and branding, the Liver Leaders Council will meet twice per year (spring- in conjunction with Digestive Diseases Week® and fall- at The Liver Meeting®) for an exclusive Liver Leaders Council Summit. These meetings will be focused on emerging issues across the spectrum of Liver Disease, bringing together industry, member-leader experts, regulators, and patients/patient advocacy groups to engage in strategic conversations around shared opportunities and challenges. 

Mission Statement

To provide a meaningful partnership between American Association for the Study of Liver Diseases Foundation and industry to collaborate and innovate through a shared commitment to invest in the future of hepatology.

Learn More

If you’d like to learn more about the Liver Leaders Council, please provide your contact information using the form here

Partnership Term:  January – December, renewals begin in October for the following year.

Coming Up!

Clinical Trials – Evolution and Innovation for Excellence

The Liver Leaders Council Summit at DDW
Saturday, May 18th 
Westin DC Downtown

Panels and Featured Speakers:

Unlocking EPIC for Successful Patient Recruitment,  presented by Dr. Ethan Weinberg

Partners Corner


Leadership Meeting Request Form

 General Information


2024 Partners

In Gratitude

We would like to recognize our Founding Partners:

Boehringer-Ingelheim, CymaBay Therapeutics, Gilead, GSK, Ipsen, Intercept Pharmaceuticals, Madrigal Pharmaceuticals, Mallinckrodt, Merck, NovoNordisk, Salix, and Takeda.